These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31600549)

  • 1. Effects of Diurnal Variation and Food on Gastrointestinal Transit of
    Kambayashi A; Sako K; Kondo H
    J Pharm Sci; 2020 Feb; 109(2):1020-1025. PubMed ID: 31600549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of small intestinal transit and colon arrival times of non-disintegrating tablets administered in the fasted state.
    Pišlar M; Brelih H; Mrhar A; Bogataj M
    Eur J Pharm Sci; 2015 Jul; 75():131-41. PubMed ID: 25769525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scintigraphic evaluation of the in vivo performance of dry-coated delayed-release tablets in humans.
    Kambayashi A; Sako K; Kondo H
    Eur J Pharm Biopharm; 2020 Jul; 152():116-122. PubMed ID: 32380166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meal-induced acceleration of tablet transit through the human small intestine.
    Fadda HM; McConnell EL; Short MD; Basit AW
    Pharm Res; 2009 Feb; 26(2):356-60. PubMed ID: 18982248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption, gastrointestinal transit, and tablet erosion of felodipine extended-release (ER) tablets.
    Abrahamsson B; Alpsten M; Hugosson M; Jonsson UE; Sundgren M; Svenheden A; Tölli J
    Pharm Res; 1993 May; 10(5):709-14. PubMed ID: 8321836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of density on the gastrointestinal transit of pellets.
    Devereux JE; Newton JM; Short MB
    J Pharm Pharmacol; 1990 Jul; 42(7):500-1. PubMed ID: 1980292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transit of pharmaceutical dosage forms through the small intestine.
    Davis SS; Hardy JG; Fara JW
    Gut; 1986 Aug; 27(8):886-92. PubMed ID: 3732895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal transit of model mini-tablet controlled release oral dosage forms in fasted human volunteers.
    Podczeck F; Course N; Newton JM; Short MB
    J Pharm Pharmacol; 2007 Jul; 59(7):941-5. PubMed ID: 17637188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug dissolution and transit in a heterogenous gastric chyme after fed administration: Semi-mechanistic modeling and simulations for an immediate-release and orodispersible tablets containing a poorly soluble drug.
    Danielak D; Gajda M; Bołtromiuk T; Sulikowska K; Kubiak B; Romański M
    Eur J Pharm Biopharm; 2024 Jul; 200():114341. PubMed ID: 38795785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Quantitative Review and Meta-models of the Variability and Factors Affecting Oral Drug Absorption-Part II: Gastrointestinal Transit Time.
    Abuhelwa AY; Foster DJR; Upton RN
    AAPS J; 2016 Sep; 18(5):1322-1333. PubMed ID: 27439620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gastric emptying of food as measured by gamma-scintigraphy and electrical impedance tomography (EIT) and its influence on the gastric emptying of tablets of different dimensions.
    Podczeck F; Mitchell CL; Newton JM; Evans D; Short MB
    J Pharm Pharmacol; 2007 Nov; 59(11):1527-36. PubMed ID: 17976264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive radionuclide esophagogastrointestinal transit study: methodology, reference values, and initial clinical experience.
    Antoniou AJ; Raja S; El-Khouli R; Mena E; Lodge MA; Wahl RL; Clarke JO; Pasricha P; Ziessman HA
    J Nucl Med; 2015 May; 56(5):721-7. PubMed ID: 25766893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects.
    Coupe AJ; Davis SS; Wilding IR
    Pharm Res; 1991 Mar; 8(3):360-4. PubMed ID: 2052525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of colonic transit of nondisintegrating tablets in healthy subjects.
    Price JM; Davis SS; Wilding IR
    Dig Dis Sci; 1993 Jun; 38(6):1015-21. PubMed ID: 8389686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of Magnetic Marker Monitoring Data to Characterize the Movement of Single Unit Dosage Forms Though the Gastrointestinal Tract Under Fed and Fasting Conditions.
    Hénin E; Bergstrand M; Weitschies W; Karlsson MO
    Pharm Res; 2016 Mar; 33(3):751-62. PubMed ID: 26553354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-scintigraphic study of the gastrointestinal transit and in vivo dissolution of a controlled release diclofenac sodium formulation in xanthan gum matrices.
    Billa N; Yuen KH; Khader MA; Omar A
    Int J Pharm; 2000 May; 201(1):109-20. PubMed ID: 10867269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems.
    Ibekwe VC; Fadda HM; McConnell EL; Khela MK; Evans DF; Basit AW
    Pharm Res; 2008 Aug; 25(8):1828-35. PubMed ID: 18465212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of gastric emptying kinetics on the drug release from enteric coated pellets in fasted state: an in vitro/in vivo correlation.
    Stefanič M; Locatelli I; Vrečer F; Sever T; Mrhar A; Bogataj M
    Eur J Pharm Biopharm; 2012 Oct; 82(2):376-82. PubMed ID: 22884655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal transit of Sinemet CR in healthy volunteers.
    Wilding IR; Davis SS; Melia CD; Hardy JG; Evans DF; Short AH; Sparrow RA
    Neurology; 1989 Nov; 39(11 Suppl 2):53-8. PubMed ID: 2685651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.